TRENTON, N.J. — Generic drugmaker Sandoz announced plans Thursday to start selling a slightly cheaper version of the EpiPen in the U.S. early next year.
The penlike injectors are used to halt life-threatening allergic reactions to insect bites, nuts and other foods. Brand-name EpiPen, which dominates the market, has been in short supply since spring because of production problems.
Sandoz will sell a pair of injectors, under the name Symjepi, for $250 without insurance. Two other generics on the market in the U.S. cost $300 a pair, including one from EpiPen seller Mylan. The company started selling its own generic after it was blasted for repeated hikes that pushed up its list price from $94 to $608 for a pair of brand-name EpiPens.
What people pay varies, though, depending on insurance, discounts and the pharmacy.
Mylan's injectors are made by a subsidiary of Pfizer, which is upgrading factories to fix quality problems. That resulted in production slowdowns. Pfizer said Thursday it's shipping some injectors and expects to ship more in the coming months.
The shortages triggered temporary shortages of other injectors, including Auvi-Q. As a result, U.S. regulators let some manufacturers extend expiration dates.
Sandox, part of Novartis AG., will sell adult injectors made by Adamis Pharmaceuticals Corp. A children's version will follow.
Israel's Teva Pharmaceutical Industries began selling limited quantities of its new generic EpiPen in the U.S. last week.
WASHINGTON — The dramatic arrest of a Chinese telecommunications executive has driven home why it will be so hard for the Trump administration to resolve its deepening conflict with China.
In the short run, the arrest of Huawei's chief financial officer heightened skepticism about the trade truce that Presidents Donald Trump and Xi Jinping reached last weekend in Buenos Aires, Argentina. On Thursday, U.S. stock markets tumbled on fears that the 90-day cease-fire won't last, before regaining most of their losses by the close of trading.
But the case of an executive for a Chinese company that's been a subject of U.S. national security concerns carries echoes well beyond tariffs or market access. Washington and Beijing are locked in a clash over which of the world's two largest economies will command economic and political dominance for decades to come.
"It's a much broader issue than just a trade dispute," said Amanda DeBusk, chair of the international trade practice at Dechert LLP. "It pulls in: Who is going to be the world leader essentially."
The Huawei executive, Meng Wanzhou, was detained by Canadian authorities in Vancouver as she was changing flights Saturday — the same day that Trump and Xi met at the Group of 20 summit in Argentina and produced a cease-fire in their trade war. The Globe and Mail newspaper, citing law enforcement sources, reported that Meng is suspected of trying to evade U.S. sanctions on Iran. She faces extradition to the United States, and a bail hearing was set for Friday.
The British bank HSBC is cooperating with U.S. authorities in its investigation, people familiar with the matter said Thursday.
Huawei, the world's biggest supplier of network gear used by phone and internet companies, has long been seen as a front for spying by the Chinese military or security services, whose cyber-spies are widely acknowledged as highly skilled. A U.S. National Security Agency cybersecurity adviser, Rob Joyce, last month accused Beijing of violating a 2015 agreement with the U.S. to halt electronic theft of intellectual property.
Other nations are increasingly being forced to choose between Chinese and U.S. suppliers for next-generation"5G" wireless technology. Washington has been pushing other countries not to buy the equipment from Huawei, arguing that the company may be working stealthily for Beijing's spymasters.
Beijing protested Meng's arrest but signaled that it doesn't want to disrupt progress toward settling its trade dispute with the Trump administration. Chinese Commerce Ministry spokesman Gao Feng said China is confident it can reach a deal during the 90 days that Trump agreed to suspend a scheduled increase in U.S. import taxes on $200 billion worth of Chinese products.
In the view of the United States and many outside analysts, China has embarked on an aggressive drive to overtake America's dominance in technology and global economic leadership. According to analysts, China has deployed predatory tactics, from forcing American and other foreign companies to hand over trade secrets in exchange for access to the Chinese market to engaging in cyber-theft.
Washington also regards Beijing's ambitious long-term development plan, "Made in China 2025," as a scheme to dominate such fields as robotics and electric vehicles by unfairly subsidizing Chinese companies and discriminating against foreign competitors.
In addition to Trump's tariffs, the administration is tightening regulations on high-tech exports to China.
Earlier this year, the United States nearly drove Huawei's biggest Chinese rival, ZTE Corp., out of business for selling equipment to North Korea and Iran in violation of U.S. sanctions. But Trump issued a reprieve, possibly in part because U.S. tech companies are major suppliers of the Chinese giant and would also have been scorched. ZTE got off with paying a $1 billion fine, changing its board and management and agreeing to let American regulators monitor its operations.
The U.S. and Chinese tech industries depend on each other so much for components that "it is very hard to decouple the two without punishing U.S. companies, without shooting ourselves in the foot," said Adam Segal, cyberspace analyst at the Council on Foreign Relations.
On Wall Street, the early plunge briefly knocked more than 700 points off the Dow Jones Industrial Average as the arrest of a senior Chinese technology executive threatened to cause another flare-up in tensions between Washington and Beijing.
The sell-off eased by late afternoon, however, after The Wall Street Journal reported that the Federal Reserve is considering breaking with its current approach of steady interest rate hikes, favoring a wait-and-see approach. That was a relief to investors worried that the Fed might raise interest rates too fast, which could choke off economic growth.
The S&P 500 index fell 4.11 points, or 0.2 percent, to 2,695.95. The benchmark index had been down as much as 2.9 percent.
The Dow dropped 79.40 points, or 0.3 percent, to 24,947.67.
The technology-heavy Nasdaq composite reversed an early loss to finish with a gain, adding 29.83 points, or 0.4 percent, to 7,188.26.